当前位置:首页 - 行情中心 - 益佰制药(600594) - 财务分析 - 现金流量表

益佰制药

(600594)

  

流通市值:34.05亿  总市值:34.05亿
流通股本:7.92亿   总股本:7.92亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,186,750,439.36518,157,625.12,498,962,508.562,026,089,841.06
  收到的税费返还1,051,843.96-75,315.1429,078.32
  收到其他与经营活动有关的现金29,329,226.7412,943,533.1257,907,028.0440,903,350.39
  经营活动现金流入小计1,217,131,510.06531,101,158.222,556,944,851.72,067,422,269.77
  购买商品、接受劳务支付的现金239,552,154.95121,999,778.04573,408,543.23415,742,559.09
  支付给职工以及为职工支付的现金267,479,787.94147,974,289.38569,805,756.03442,484,504.43
  支付的各项税费88,282,027.6338,231,827.59193,818,082.34142,540,402.06
  支付其他与经营活动有关的现金451,264,713.86215,368,911.081,133,039,433.22866,851,481.58
  经营活动现金流出小计1,046,578,684.38523,574,806.092,470,071,814.821,867,618,947.16
  经营活动产生的现金流量净额170,552,825.687,526,352.1386,873,036.88199,803,322.61
二、投资活动产生的现金流量:
  收回投资收到的现金--13,007.4113,007.41
  处置固定资产、无形资产和其他长期资产收回的现金净额22,486.822,486.81,170,770977,510
  收到的其他与投资活动有关的现金--11,303,10411,303,104
  投资活动现金流入小计22,486.822,486.812,486,881.4112,293,621.41
  购建固定资产、无形资产和其他长期资产支付的现金13,770,190.216,671,319.5696,321,108.5268,676,924.41
  投资支付的现金--20,000,000-
  支付其他与投资活动有关的现金--2,601.482,601.48
  投资活动现金流出小计13,770,190.216,671,319.56116,323,71068,679,525.89
  投资活动产生的现金流量净额-13,747,703.41-6,648,832.76-103,836,828.59-56,385,904.48
三、筹资活动产生的现金流量:
  取得借款收到的现金402,999,999.5222,999,999.5560,000,000380,000,000
  筹资活动现金流入小计402,999,999.5222,999,999.5560,000,000380,000,000
  偿还债务支付的现金363,260,000277,351,871.42596,249,335.14498,303,855.41
  分配股利、利润或偿付利息支付的现金14,856,616.077,642,247.5886,874,598.4678,919,005.41
  支付其他与筹资活动有关的现金7,543,503.82,814,903.836,582,433.5933,986,452.45
  筹资活动现金流出小计385,660,119.87287,809,022.8719,706,367.19611,209,313.27
  筹资活动产生的现金流量净额17,339,879.63-64,809,023.3-159,706,367.19-231,209,313.27
四、汇率变动对现金及现金等价物的影响-5,555.11-1,248.57-3,249.09-12,532
五、现金及现金等价物净增加额174,139,446.79-63,932,752.5-176,673,407.99-87,804,427.14
  加:期初现金及现金等价物余额519,007,309.87519,007,309.87695,680,717.86695,680,717.86
  期末现金及现金等价物余额693,146,756.66455,074,557.37519,007,309.87607,876,290.72
补充资料:
  净利润-22,357,904.18--334,673,987.38-
  资产减值准备17,658,871.98-78,911,500.4-
  固定资产和投资性房地产折旧74,806,366.67-167,859,776.39-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧74,806,366.67-167,859,776.39-
  无形资产摊销8,087,814.12-16,035,982.71-
  长期待摊费用摊销11,225,552.98-34,337,546.15-
  处置固定资产、无形资产和其他长期资产的损失-17,429.53--779,233.88-
  固定资产报废损失253,161.04-1,736,304.62-
  财务费用15,859,765.05-36,501,106.81-
  投资损失512,541.25--338,405.75-
  递延所得税-9,500,590.5--37,462,444.42-
  其中:递延所得税资产减少-8,240,227.33--34,761,710.32-
    递延所得税负债增加-1,260,363.17--2,700,734.1-
  存货的减少20,622,506.6-41,748,007.2-
  经营性应收项目的减少109,333,174.15-184,277,936.34-
  经营性应付项目的增加-60,766,093.23--105,378,453.42-
  现金的期末余额693,146,756.66-519,007,309.87-
  减:现金的期初余额519,007,309.87-695,680,717.86-
  现金及现金等价物的净增加额174,139,446.79--176,673,407.99-
公告日期2025-08-212025-04-262025-04-262024-10-26
审计意见(境内)标准无保留意见
TOP↑